Reviewed by Michael Gill, B. Sc.
25 Vision Clinical Trials Near Me
Top Hospitals for Vision Clinical Trials
Image of Rothman Institute in Pennsylvania.
Rothman Institute
Philadelphia
3Active Trials
0All Time Trials for Vision
2016First Vision Trial
Image of National Institutes of Health Clinical Center in Maryland.
National Institutes of Health Clinical Center
Bethesda
2Active Trials
0All Time Trials for Vision
2021First Vision Trial
Top Cities for Vision Clinical Trials
Vision Clinical Trials by Phase of Trial
N/A Vision Clinical Trials
50Active Vision Clinical Trials
50Number of Unique Treatments
85Number of Active Locations
Patients: CDS Alert System for Sensory Deficit ScreeningTEST Lensweight loss strategiesBiofeedback trainingCollaborative care PlusFractional CO2 LaserSenaptec Strobe GlassesEnhanced Intervention
Vision Clinical Trials by Age Group
< 18 Vision Clinical Trials
8Active Vision Clinical Trials
Patients: CDS Alert System for Sensory Deficit ScreeningOffice-based verg/accomm therapy (OBVAT)Fruit and vegetable provisionEnhanced Sleep Health EducationB groupSFM + Behavioral RehearsalPropranololVision Therapy
Top Treatments for Vision Clinical Trials
Treatment Name
Active Vision Clinical Trials
All Time Trials for Vision
First Recorded Vision Trial
Patients: CDS Alert System for Sensory Deficit Screening
1
1
2022
TEST Lens
1
1
2022
weight loss strategies
1
1
2022
Biofeedback training
1
1
2021
Sibeprenlimab 400 mg s.c. q 4weeks
1
1
2022

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 21st, 2021

Last Reviewed: November 14th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010 Mar;71(3):446-54. doi: 10.1016/j.gie.2009.10.027. https://pubmed.ncbi.nlm.nih.gov/201895032 Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010 Mar;71(3):446-54. doi: 10.1016/j.gie.2009.10.027. No abstract available. https://pubmed.ncbi.nlm.nih.gov/201895033 Scheiman M, Kulp MT, Cotter SA, Lawrenson JG, Wang L, Li T. Interventions for convergence insufficiency: a network meta-analysis. Cochrane Database Syst Rev. 2020 Dec 2;12:CD006768. doi: 10.1002/14651858.CD006768.pub3. https://pubmed.ncbi.nlm.nih.gov/332633594 Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012 May;96(5):614-8. doi: 10.1136/bjophthalmol-2011-300539. Epub 2011 Dec 1. Review. https://pubmed.ncbi.nlm.nih.gov/221339885 Xiong W, Hietala SF, Nyberg J, Papasouliotis O, Johne A, Berghoff K, Goteti K, Dong J, Girard P, Venkatakrishnan K, Strotmann R. Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations. Cancer Chemother Pharmacol. 2022 Jul;90(1):53-69. doi: 10.1007/s00280-022-04441-3. Epub 2022 Jun 30. https://pubmed.ncbi.nlm.nih.gov/357712596 Xiong W, Hietala SF, Nyberg J, Papasouliotis O, Johne A, Berghoff K, Goteti K, Dong J, Girard P, Venkatakrishnan K, Strotmann R. Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations. Cancer Chemother Pharmacol. 2022 Jun 30. doi: 10.1007/s00280-022-04441-3. [Epub ahead of print] https://pubmed.ncbi.nlm.nih.gov/357712597 Forrest CB, Meltzer LJ, Marcus CL, de la Motte A, Kratchman A, Buysse DJ, Pilkonis PA, Becker BD, Bevans KB. Development and validation of the PROMIS Pediatric Sleep Disturbance and Sleep-Related Impairment item banks. Sleep. 2018 Jun 1;41(6). doi: 10.1093/sleep/zsy054. https://pubmed.ncbi.nlm.nih.gov/295462868 Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012 May;96(5):614-8. doi: 10.1136/bjophthalmol-2011-300539. Epub 2011 Dec 1. https://pubmed.ncbi.nlm.nih.gov/221339889 Shimizu K, Misawa A, Suzuki Y. Toric intraocular lenses: correcting astigmatism while controlling axis shift. J Cataract Refract Surg. 1994 Sep;20(5):523-6. doi: 10.1016/s0886-3350(13)80232-5. https://pubmed.ncbi.nlm.nih.gov/799640810 Mindell JA, Sedmak R, Boyle JT, Butler R, Williamson AA. Sleep Well!: A Pilot Study of an Education Campaign to Improve Sleep of Socioeconomically Disadvantaged Children. J Clin Sleep Med. 2016 Dec 15;12(12):1593-1599. doi: 10.5664/jcsm.6338. https://pubmed.ncbi.nlm.nih.gov/27655459